Blikman, T.
Rienstra, W.
van Raaij, T. M.
ten Hagen, A. J.
Dijkstra, B.
Zijlstra, W. P.
Bulstra, S. K.
Stevens, M.
van den Akker-Scheek, I.
Article History
Received: 15 January 2021
Accepted: 10 January 2022
First Online: 5 February 2022
Declarations
:
: The DOA study was approved by the local Medical Ethics Committee of the University Medical Center Groningen (METc 2014/087) and was conducted according to the principles of the Declaration of Helsinki (64th, 2013) and the Good Clinical Practice standard (GCP), and in compliance with the Medical Research Involving Human Subjects Act (WMO). Written informed consent was obtained from all patients prior to participating.This trial is registered in the Netherlands Trial Registry, which is part of the Dutch Cochrane Center (NTR4744, first registration 15/08/2014).
: Not applicable.
: The authors declare that they have no competing interests.